Eli Lilly presents new data for their mirikizimab treatment for Crohn’s disease.
List view / Grid view
Icahn School of Medicine at Mount Sinai
Filter the results
Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...